As of May 30, 2026, Recursion Pharmaceuticals's top three insider holders are Ventures Iv, L.P. Lux (Other, 13.02Mn shares), Investment Co Pjsc Mubadala (TenPercentOwner, 12.99Mn shares), Christopher Gibson (Chief Executive Officer, 9.45Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| R. Martin Chavez | - | 60,078 | 0 | 03 Apr, 2024 |
| Robert Hershberg | - | 73,732 | 0 | 23 Jun, 2025 |
| David J Mauro | Chief Medical Officer | 225,429 | 0 | 19 Nov, 2024 |
| Ventures Iv, L.P. Lux | - | 13,021,519 | 0 | 09 Dec, 2021 |
| Investment Co Pjsc Mubadala | - | 0 | 12,985,927 | 03 Mar, 2023 |
| Ben R Taylor | Chief Financial Officer | 1,132,290 | 0 | 08 Apr, 2026 |
| Terry-Ann Burrell | - | 71,254 | 0 | 03 Jul, 2024 |
| Elaine D Sun | - | 47,557 | 0 | 23 Jun, 2025 |
| Zachary Bogue | - | 9,378 | 0 | 06 Jul, 2023 |
| Dean Y Li | - | 0 | 2,645,900 | 09 Dec, 2021 |
| Zavain Dar | - | 147,231 | 0 | 02 Apr, 2026 |
| Michael Secora | Chief Financial Officer | 1,487,694 | 0 | 15 Nov, 2024 |
| Ramona Doyle | Chief Medical Officer | 121,110 | 0 | 16 May, 2022 |
| Shafique Virani | Chief Business Officer | 136,748 | 0 | 18 Jan, 2024 |
| Blake Borgeson | - | 6,229,863 | 0 | 08 Apr, 2026 |
| Christopher Gibson | Chief Executive Officer | 8,201,216 | 1,246,875 | 07 Dec, 2021 |
| Tina Marriott | President And Coo | 506,852 | 0 | 19 Nov, 2024 |
| David Hallett | Chief Scientific Officer | 1,097,151 | 0 | 17 Feb, 2026 |
| Najat Khan | Ceo And President | 2,262,085 | 0 | 11 Mar, 2026 |
| Franziska Michor | - | 127,053 | 0 | 23 Jun, 2025 |
| Namandje Bumpus | - | 47,557 | 0 | 23 Jun, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 06 Apr, 2026 | Ben R Taylor | Class A Common Stock | D | 48,028 | $3.11 | 1,132,290 | D | F |
| 07 Apr, 2026 | Blake Borgeson | Class A Common Stock | D | 30,000 | $3.10 | 6,229,863 | D | S |
| 07 Apr, 2026 | Christopher Gibson | Class A Common Stock | A | 40,000 | $0.00 | 946,556 | D | C |
| 06 Apr, 2026 | Ben R Taylor | Class A Common Stock | D | 48,028 | $3.11 | 1,132,290 | D | F |
| 06 Apr, 2026 | Ben R Taylor | Class A Common Stock | D | 48,028 | $3.11 | 1,132,290 | D | F |
| 07 Apr, 2026 | Christopher Gibson | Class A Common Stock | D | 40,000 | $3.10 | 906,556 | D | S |
| 07 Apr, 2026 | Christopher Gibson | Class B Common Stock | D | 40,000 | $0.00 | 4,443,334 | D | C |
| 01 Apr, 2026 | Dean Y Li | Class A Common Stock | A | 3,268 | $0.00 | 1,244,177 | D | A |
| 01 Apr, 2026 | Zavain Dar | Class A Common Stock | A | 4,902 | $0.00 | 147,231 | D | A |
| 22 Apr, 2026 | Christopher Gibson | Class A Common Stock | A | 40,000 | $0.00 | 946,556 | D | C |
| 22 Apr, 2026 | Christopher Gibson | Class A Common Stock | D | 40,000 | $3.61 | 906,556 | D | S |
| 22 Apr, 2026 | Christopher Gibson | Class B Common Stock | D | 40,000 | $0.00 | 4,403,334 | D | C |
| 23 Mar, 2026 | Christopher Gibson | Class A Common Stock | A | 40,000 | $0.00 | 946,556 | D | C |
| 23 Mar, 2026 | Christopher Gibson | Class A Common Stock | D | 40,000 | $3.25 | 906,556 | D | S |
| 23 Mar, 2026 | Christopher Gibson | Class B Common Stock | D | 40,000 | $0.00 | 4,483,334 | D | C |
| 16 Mar, 2026 | Ben R Taylor | Class A Common Stock | D | 7,075 | $3.42 | 1,188,274 | D | F |
| 16 Mar, 2026 | Ben R Taylor | Class A Common Stock | D | 7,075 | $3.42 | 1,188,274 | D | F |
| 16 Mar, 2026 | Ben R Taylor | Class A Common Stock | D | 7,075 | $3.42 | 1,188,274 | D | F |
| 16 Mar, 2026 | Ben R Taylor | Class A Common Stock | D | 7,075 | $3.42 | 1,188,274 | D | F |
| 17 Mar, 2026 | Ben R Taylor | Class A Common Stock | D | 7,956 | $3.39 | 1,180,318 | D | S |